Trials / Conditions / Adult Hepatocellular Carcinoma

Adult Hepatocellular Carcinoma

10 registered clinical trials studyying Adult Hepatocellular Carcinoma — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant NCT02379377	M.D. Anderson Cancer Center	Phase 1
Completed	MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer NCT02683200	Jonsson Comprehensive Cancer Center	EARLY_Phase 1
Completed	PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection NCT01395030	Queen's Medical Center	Phase 2
Terminated	MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy NCT01239355	National Cancer Institute (NCI)	Phase 2
Completed	Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery NCT01899261	Albert Einstein College of Medicine	N/A
Completed	MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer NCT02578602	University of Southern California	Phase 1
Completed	Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence NCT02447679	Chang Gung Memorial Hospital	Phase 2
Completed	Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Isl NCT01010126	National Cancer Institute (NCI)	Phase 2
Completed	Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer NCT01008566	National Cancer Institute (NCI)	Phase 1
Completed	Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surg NCT00608361	National Cancer Institute (NCI)	Phase 1